Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 93-14-1
Drug Levels and Effects
Summary of Use during Lactation
Neither the excretion of guaifenesin in milk nor its effect on breastfed infants have been studied. It is unlikely that with usual maternal doses amounts in breastmilk would harm the nursing infant, especially in infants over 2 months of age. It is best to avoid the use of products with a high alcohol content while nursing.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Guaifenesin
CAS Registry Number
93-14-1
Drug Class
- Breast Feeding
- Lactation
- Expectorants
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Acetaminophen.[Drugs and Lactation Database (...]Review Acetaminophen.. Drugs and Lactation Database (LactMed®). 2006
- [Investigations of guaifenesine metabolism with gas chromatography-mass spectrometry].[Arch Toxicol. 1980][Investigations of guaifenesine metabolism with gas chromatography-mass spectrometry].Kauert G, von Meyer L, Drasch G. Arch Toxicol. 1980 Jul; 45(2):149-59.
- [Guaiacol-glycerin ether; reorganin (My 301) in the treatment of eclampsia].[Minerva Anestesiol. 1955][Guaiacol-glycerin ether; reorganin (My 301) in the treatment of eclampsia].BERTOLETTI P, MORRA C. Minerva Anestesiol. 1955 Oct; 21(10):264-6.
- OBSERVATIONS ON THE HAEMOLYTIC ACTIVITY OF GUAIACOL GLYCEROL ETHER.[Br J Anaesth. 1963]OBSERVATIONS ON THE HAEMOLYTIC ACTIVITY OF GUAIACOL GLYCEROL ETHER.MOSTERT JW, METZ J. Br J Anaesth. 1963 Aug; 35:461-4.
- Review Dyphylline.[Drugs and Lactation Database (...]Review Dyphylline.. Drugs and Lactation Database (LactMed®). 2006
- Guaifenesin - Drugs and Lactation Database (LactMed®)Guaifenesin - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...